Pfizer is steering much of its pandemic revenue into oncology, as Chief Executive Albert ...
Pfizer's stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live with the coronavirus, and Pfizer's stock has plunged as a result. Faced with patent ...